ENTRY       D09029                      Drug
NAME        Velaglucerase alfa (USAN);
            Velaglucerase alfa (genetical recombination) (JAN);
            Vpriv (TN)
PRODUCT     VPRIV (Takeda Pharmaceuticals America)
FORMULA     C2532H3854N672O711S16
EXACT_MASS  55562.1608
MOL_WEIGHT  55596.809
SEQUENCE    ARPCIPKSFG YSSVVCVCNA TYCDSFDPPT FPALGTFSRY ESTRSGRRME LSMGPIQANH
            TGTGLLLTLQ PEQKFQKVKG FGGAMTDAAA LNILALSPPA QNLLLKSYFS EEGIGYNIIR
            VPMASCDFSI RTYTYADTPD DFQLHNFSLP EEDTKLKIPL IHRALQLAQR PVSLLASPWT
            SPTWLKTNGA VNGKGSLKGQ PGDIYHQTWA RYFVKFLDAY AEHKLQFWAV TAENEPSAGL
            LSGYPFQCLG FTPEHQRDFI ARDLGPTLAN STHHNVRLLM LDDQRLLLPH WAKVVLTDPE
            AAKYVHGIAV HWYLDFLAPA KATLGETHRL FPNTMLFASE ACVGSKFWEQ SVRLGSWDRG
            MQYSHSIITN LLYHVVGWTD WNLALNPEGG PNWVRNFVDS PIIVDITKDT FYKQPMFYHL
            GHFSKFIPEG SQRVGLVASQ KNDLDAVALM HPDGSAVVVV LNRSSKDVPL TIKDPAVGFL
            ETISPGYSIH TYLWRRQ (Glycosylation site: 19; 59; 146; 270; 462)
  TYPE      Peptide
REMARK      Therapeutic category: 3959
            ATC code: A16AB10
            Product: D09029<JP/US>
EFFICACY    Lysosomal storage disease treatment, Enzyme replacement (glucocerebrosidase)
  DISEASE   Type 1 Gaucher disease [DS:H00126]
  TYPE      Enzyme replacement therapy product
TARGET      GBA* [HSA_VAR:2629v1] [HSA:2629] [KO:K01201]
  PATHWAY   hsa00600(2629)  Sphingolipid metabolism
            hsa00511(2629)  Other glycan degradation
            hsa04142(2629)  Lysosome
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             A ALIMENTARY TRACT AND METABOLISM
              A16 OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
               A16A OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
                A16AB Enzymes
                 A16AB10 Velaglucerase alfa
                  D09029  Velaglucerase alfa (USAN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Genetic, Enzyme, or Protein Disorder: Replacement, Modifiers, Treatment
              Velaglucerase Alfa
               D09029  Velaglucerase alfa (USAN)
            Therapeutic category of drugs in Japan [BR:br08301]
             3  Agents affecting metabolism
              39  Other agents affecting metabolism
               395  Enzyme preparations
                3959  Others
                 D09029  Velaglucerase alfa (USAN); Velaglucerase alfa (genetical recombination) (JAN)
            Target-based classification of drugs [BR:br08310]
             Enzymes
              Hydrolases (EC3)
               Glycosidases
                GBA* [HSA_VAR:2629v1]
                 D09029  Velaglucerase alfa (USAN) &lt;JP/US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D09029
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D09029
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D09029
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D09029
            Pharmacogenomic biomarkers [br08341.html]
             Germline mutations in genetic disorder treatments
              D09029
DBLINKS     CAS: 884604-91-5
            PubChem: 96025712
///
